Immunology Innovation Program

At argenx, innovation starts with a question and advances through collaboration. Our Immunology Innovation Program (IIP) is a co-creation engine designed to translate breakthrough immunology insights into differentiated antibody-based medicines.

Through the IIP, we partner closely with leading academic and clinical researchers, combining their deep disease and target biology expertise with our world-class antibody engineering and development capabilities. Together, we work across discovery, de-risking, and development to move promising ideas efficiently toward clinical proof of concept.

Built on transparency, long-term commitment, and shared success, the IIP reflects how argenx works best – side-by-side with collaborators, advancing science that has the potential to define what’s possible for patients.